International validation study for interim PET in ABVD-treated, advanced-stage Hodgkin lymphoma: interpretation criteria and concordance rate among reviewers

A Biggi, A Gallamini, S Chauvie… - Journal of Nuclear …, 2013 - Soc Nuclear Med
At present, there are no standard criteria that have been validated for interim PET reporting
in lymphoma. In 2009, an international workshop attended by hematologists and nuclear …

The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre …

C Agostinelli, A Gallamini, L Stracqualursi… - The Lancet …, 2016 - thelancet.com
Background Early-interim fluorodeoxyglucose (FDG)-PET scan after two ABVD (doxorubicin,
bleomycin, vinblastine, and dacarbazine) chemotherapy courses (PET-2) represents the …

Report on the Second International Workshop on interim positron emission tomography in lymphoma held in Menton, France, 8–9 April 2010

M Meignan, A Gallamini, C Haioun… - Leukemia & …, 2010 - Taylor & Francis
One hundred and fifty hemato-oncologists and nuclear medicine specialists from more than
20 countries joined in April 2010 the 2-day Second International Workshop on interim PET in …

[HTML][HTML] Adapted treatment guided by interim PET-CT scan in advanced Hodgkin's lymphoma

P Johnson, M Federico, A Kirkwood… - … England Journal of …, 2016 - Mass Medical Soc
Background We tested interim positron-emission tomography–computed tomography (PET-
CT) as a measure of early response to chemotherapy in order to guide treatment for patients …

18F-FDG PET after 2 cycles of ABVD predicts event-free survival in early and advanced Hodgkin lymphoma

JJ Cerci, LF Pracchia, CCG Linardi… - Journal of Nuclear …, 2010 - Soc Nuclear Med
Our objective was to assess the prognostic value of 18F-FDG PET after 2 cycles of
chemotherapy using doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) in …

[HTML][HTML] The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the …

A Gallamini, SF Barrington, A Biggi, S Chauvie… - …, 2014 - ncbi.nlm.nih.gov
A retrospective, international, multicenter study was undertaken to assess:(i) the prognostic
role of 'interim'positron emission tomography performed during treatment with doxorubicin …

Early interim 18F-FDG PET in Hodgkin's lymphoma: evaluation on 304 patients

PL Zinzani, L Rigacci, V Stefoni, A Broccoli… - European journal of …, 2012 - Springer
Purpose The use of early (interim) PET restaging during first-line therapy of Hodgkin's
lymphoma (HL) in clinical practice has considerably increased because of its ability to …

Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in …

C Kobe, M Dietlein, J Franklin… - Blood, The Journal …, 2008 - ashpublications.org
In the HD15 trial of the German Hodgkin Study Group, the negative predictive value (NPV) of
positron emission tomography (PET) using [18F]-fluorodeoxyglucose in advanced-stage …

Prognostic value of interim FDG PET/CT in Hodgkin's lymphoma patients treated with interim response-adapted strategy: comparison of International Harmonization …

PY Le Roux, T Gastinne, S Le Gouill, E Nowak… - European journal of …, 2011 - Springer
Abstract Purpose Interim 2-[18 F] fluoro-2-deoxy-D-glucose positron emission tomography
(FDG PET) has shown to be an accurate predictor of prognosis in Hodgkin's lymphoma (HL) …

[HTML][HTML] Prognostic significance of mid-and post-ABVD PET imaging in Hodgkin's lymphoma: the importance of involved-field radiotherapy

DJ Sher, PM Mauch, A Van Den Abbeele… - Annals of …, 2009 - Elsevier
Background Although positron emission tomography (PET) response to chemotherapy (CT)
has prognostic significance in Hodgkin's lymphoma (HL), it is unclear whether patients with …